Biohaven Ltd (BHVN)
38.72
-0.89
(-2.25%)
USD |
NYSE |
Apr 24, 16:00
38.70
-0.02
(-0.05%)
Pre-Market: 20:00
Biohaven Price: 38.72 for April 24, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 24, 2024 | 40.19 | 40.62 | 38.38 | 38.72 | 963830.0 |
Apr 23, 2024 | 40.54 | 41.88 | 39.25 | 39.61 | 2.087M |
Apr 22, 2024 | 39.70 | 39.70 | 38.19 | 38.33 | 1.132M |
Apr 19, 2024 | 42.36 | 43.24 | 37.61 | 38.99 | 3.353M |
Apr 18, 2024 | 42.90 | 43.31 | 41.00 | 42.16 | 3.668M |
Apr 17, 2024 | 44.14 | 45.60 | 42.54 | 44.03 | 1.040M |
Apr 16, 2024 | 44.77 | 45.07 | 42.34 | 43.77 | 1.955M |
Apr 15, 2024 | 50.96 | 52.50 | 43.58 | 44.77 | 3.402M |
Apr 12, 2024 | 53.49 | 53.70 | 52.12 | 53.08 | 792385.0 |
Apr 11, 2024 | 51.53 | 53.80 | 51.20 | 53.49 | 697997.0 |
Apr 10, 2024 | 50.37 | 51.60 | 49.77 | 51.06 | 718485.0 |
Apr 09, 2024 | 51.62 | 53.13 | 50.85 | 51.98 | 756411.0 |
Apr 08, 2024 | 52.29 | 52.42 | 50.02 | 51.41 | 834721.0 |
Apr 05, 2024 | 51.93 | 53.73 | 51.36 | 52.52 | 584172.0 |
Apr 04, 2024 | 52.70 | 55.72 | 51.60 | 52.33 | 879794.0 |
Apr 03, 2024 | 50.25 | 52.74 | 50.25 | 52.28 | 934434.0 |
Apr 02, 2024 | 50.99 | 52.15 | 50.10 | 50.79 | 1.230M |
Apr 01, 2024 | 54.69 | 54.69 | 51.57 | 52.06 | 936204.0 |
Mar 28, 2024 | 57.02 | 57.02 | 54.65 | 54.69 | 841480.0 |
Mar 27, 2024 | 56.88 | 57.07 | 54.22 | 57.02 | 834506.0 |
Mar 26, 2024 | 58.20 | 59.53 | 56.20 | 56.29 | 1.815M |
Mar 25, 2024 | 55.62 | 56.32 | 55.13 | 55.23 | 1.220M |
Mar 22, 2024 | 55.63 | 56.43 | 55.25 | 55.85 | 1.012M |
Mar 21, 2024 | 60.17 | 60.46 | 55.85 | 55.88 | 1.792M |
Mar 20, 2024 | 56.02 | 59.37 | 55.43 | 59.36 | 921317.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.30
Minimum
Sep 30 2022
59.75
Maximum
Mar 13 2024
25.45
Average
19.28
Median
Price Benchmarks
Eli Lilly and Co | 732.20 |
Amgen Inc | 273.01 |
Regeneron Pharmaceuticals Inc | 906.54 |
Scholar Rock Holding Corp | 14.09 |
Alnylam Pharmaceuticals Inc | 143.80 |
Price Related Metrics
Price to Book Value | 7.388 |
Earnings Yield | -14.77% |
Market Cap | 3.162B |